These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11435135)

  • 1. Purification and partial characterisation of alpha(2)-antiplasmin and plasmin(ogen) from ostrich plasma.
    Thomas AR; Naudé RJ; Oelofsen W; Naganuma T; Muramoto K
    Comp Biochem Physiol B Biochem Mol Biol; 2001 Jul; 129(4):809-20. PubMed ID: 11435135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and partial characterization of a myofibril-bound serine protease from ostrich skeletal muscle.
    Tshidino SC; Krause J; Adebiyi AP; Muramoto K; Naudé RJ
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Oct; 154(2):229-34. PubMed ID: 19559097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
    Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
    Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The purification and characterisation of m-calpain from ostrich brain.
    Mkwetshana N; Naudé RJ; Oelofsen W; Muramoto K; Naganuma T
    Int J Biochem Cell Biol; 2002 Apr; 34(4):337-47. PubMed ID: 11854033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isolation and partial characterization of precursor forms of ostrich carboxypeptidase.
    Mkwetshana NT; Naudé RJ; Oelofsen W; Naganuma T; Muramoto K
    Int J Biochem Cell Biol; 1999 Feb; 31(2):331-43. PubMed ID: 10216965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ostrich antithrombin III: kinetics and mechanism of inhibition of ostrich thrombin.
    Frost CL; Naudé RJ; Muramoto K
    Int J Biochem Cell Biol; 2002 Sep; 34(9):1164-71. PubMed ID: 12009311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activation kinetics of mammalian plasminogens.
    Wohl RC; Sinio L; Summaria L; Robbins KC
    Biochim Biophys Acta; 1983 May; 745(1):20-31. PubMed ID: 6682680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate.
    Sazonova IY; Thomas BM; Gladysheva IP; Houng AK; Reed GL
    J Thromb Haemost; 2007 Oct; 5(10):2087-94. PubMed ID: 17883703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ostrich pepsinogens I and II: purification, activation and chemical and immunochemical characterization of the enzymes from the proventriculus.
    Pletschke BI; Naudé RJ; Oelofsen W; Muramoto K; Yamauchi F
    Int J Biochem Cell Biol; 1995 Jun; 27(6):613-24. PubMed ID: 7671140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
    Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
    Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of ostrich prothrombin.
    Frost C; Naudé R; Oelofsen W; Muramoto K; Naganuma T; Ogawa T
    Int J Biochem Cell Biol; 2000; 32(11-12):1151-9. PubMed ID: 11137455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity-chromatographic purification of human alpha 2-antiplasmin.
    Wiman B
    Biochem J; 1980 Oct; 191(1):229-32. PubMed ID: 6907016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and some properties of rat alpha 2-plasmin inhibitor.
    Kumada T; Abiko Y
    Thromb Res; 1984 Oct; 36(2):143-52. PubMed ID: 6438828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor.
    Sasaki T; Morita T; Iwanaga S
    J Biochem; 1986 Jun; 99(6):1699-705. PubMed ID: 3745142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
    Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
    Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.
    Clemmensen I; Petersen LC; Kluft C
    Eur J Biochem; 1986 Apr; 156(2):327-33. PubMed ID: 3009181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The purification and characterization of mu-calpain and calpastatin from ostrich brain.
    Mkwetshana N; Naudé RJ; Muramoto K
    Int J Biochem Cell Biol; 2002 Jun; 34(6):613-24. PubMed ID: 11943592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.